Minimally Invasive Biportal Endoscopic Spinal Cord Stimulation : Technical Report and Case Series.

IF 1.7 4区医学 Q4 CLINICAL NEUROLOGY

Journal of Korean Neurosurgical Society Pub Date : 2025-10-02 DOI:10.3340/jkns.2025.0051

Young San Ko, Dae-Chul Cho

{"title":"Minimally Invasive Biportal Endoscopic Spinal Cord Stimulation : Technical Report and Case Series.","authors":"Young San Ko, Dae-Chul Cho","doi":"10.3340/jkns.2025.0051","DOIUrl":null,"url":null,"abstract":"Objective: The insertion of a surgical paddle lead for spinal cord stimulation (SCS) is a cornerstone therapy for chronic refractory pain, with lower impedance and reduced battery usage than a percutaneous lead. However, the greater invasiveness of this procedure can cause complications.Methods: This study introduces a novel SCS technique using the unilateral biportal endoscopy (UBE) approach, illustrated through intraoperative images and endoscopic videos. We retrospectively reviewed 14 patients who underwent SCS using the UBE technique. Clinical, surgical, and radiological data were collected from electronic medical records and surgical videos.Results: A total of 14 patients (five females, nine males) were included in the study. The mean endoscopic operating time was 76.3±22.3 minutes. After the trial period, 13 patients (92.8%, 13/14) improved and underwent permanent implantation. The complication rate was 21.4%, with two cases of thoracic radiculopathy and one case of asymmetrical lead positioning. No lead migration was observed in these 13 patients.Conclusion: This study demonstrated the safety and efficacy of UBE-SCS as a minimally invasive alternative to conventional techniques, with high success rates and acceptable complications. However, further large-scale, long-term comparative studies are needed.","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Neurosurgical Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3340/jkns.2025.0051","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The insertion of a surgical paddle lead for spinal cord stimulation (SCS) is a cornerstone therapy for chronic refractory pain, with lower impedance and reduced battery usage than a percutaneous lead. However, the greater invasiveness of this procedure can cause complications.

Methods: This study introduces a novel SCS technique using the unilateral biportal endoscopy (UBE) approach, illustrated through intraoperative images and endoscopic videos. We retrospectively reviewed 14 patients who underwent SCS using the UBE technique. Clinical, surgical, and radiological data were collected from electronic medical records and surgical videos.

Results: A total of 14 patients (five females, nine males) were included in the study. The mean endoscopic operating time was 76.3±22.3 minutes. After the trial period, 13 patients (92.8%, 13/14) improved and underwent permanent implantation. The complication rate was 21.4%, with two cases of thoracic radiculopathy and one case of asymmetrical lead positioning. No lead migration was observed in these 13 patients.

Conclusion: This study demonstrated the safety and efficacy of UBE-SCS as a minimally invasive alternative to conventional techniques, with high success rates and acceptable complications. However, further large-scale, long-term comparative studies are needed.

查看原文本刊更多论文

微创双门静脉内窥镜脊髓刺激：技术报告和病例系列。

目的：与经皮导联相比，脊髓刺激（SCS）手术导联的插入具有更低的阻抗和更少的电池使用，是治疗慢性难治性疼痛的基础疗法。然而，这种手术的侵入性较大，可能会引起并发症。方法：本研究采用单侧双门静脉内窥镜（UBE）入路，通过术中图像和内窥镜视频说明一种新的SCS技术。我们回顾性分析了14例使用UBE技术接受SCS的患者。临床、手术和放射学数据从电子病历和手术录像中收集。结果：共纳入14例患者，其中女性5例，男性9例。平均内镜手术时间76.3±22.3分钟。试验结束后，13例患者（92.8%,13/14）改善并行永久植入术。并发症发生率为21.4%，其中胸神经根病2例，导联定位不对称1例。13例患者未见铅迁移。结论：本研究证明了UBE-SCS作为常规技术的微创替代方案的安全性和有效性，成功率高，并发症可接受。然而，需要进一步大规模、长期的比较研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Korean Neurosurgical Society 医学-临床神经学

CiteScore

2.90

自引率

6.20%

发文量

109

审稿时长

3-8 weeks

期刊介绍： The Journal of Korean Neurosurgical Society (J Korean Neurosurg Soc) is the official journal of the Korean Neurosurgical Society, and published bimonthly (1st day of January, March, May, July, September, and November). It launched in October 31, 1972 with Volume 1 and Number 1. J Korean Neurosurg Soc aims to allow neurosurgeons from around the world to enrich their knowledge of patient management, education, and clinical or experimental research, and hence their professionalism. This journal publishes Laboratory Investigations, Clinical Articles, Review Articles, Case Reports, Technical Notes, and Letters to the Editor. Our field of interest involves clinical neurosurgery (cerebrovascular disease, neuro-oncology, skull base neurosurgery, spine, pediatric neurosurgery, functional neurosurgery, epilepsy, neuro-trauma, and peripheral nerve disease) and laboratory work in neuroscience.